BOSTON BIOTECHNOLOGY CORPORATION

Company Information

Company Name
BOSTON BIOTECHNOLOGY CORPORATION
Address
BOSTON BIOTECHNOLOGY CORPORATION
64 GROVE STREET
WATERTOWN, MA, 02472
Phone
1 617-658-7701
URL
n/a
DUNS
n/a
Number of Employees
n/a
Hubzone Owned:
N
Minority Owned:
N
Woman Owned:
N

Award Totals

PROGRAM/PHASE
AWARD AMOUNT ($)
NUMBER OF AWARDS
SBIR Phase I
$871,141.00
10
SBIR Phase II
$1,877,831.00
3
Chart code to be here

Award List

  1. AS A FUNCTION OF ETHYLENE OXIDE STERILIZATION AND STORAGE TIME.

    Amount: $50,000.00

    AS A FUNCTION OF ETHYLENE OXIDE STERILIZATION AND STORAGE TIME.PRIMARY BILIARY CIRRHOSIS (PBC) IS A DEGENERATIVE LIVER DISEASE OF UNKNOWN ETIOLOGY WHICH FREQUENTLY RESULTS IN DEATH WITHIN 5 TO 10 YEAR ...

    SBIR Phase I 1985 Department of Health and Human Services
  2. THE LONG-TERM OBJECTIVE OF THIS PROJECT IS THE DEVELOPMENT OF IMPROVED NONISOTOPIC HOMOGENEOUS IMMUNOASSAYS.

    Amount: $50,000.00

    THE LONG-TERM OBJECTIVE OF THIS PROJECT IS THE DEVELOPMENT OF IMPROVED NONISOTOPIC HOMOGENEOUS IMMUNOASSAYS. INITIALLY, A METHOD WILL BE DEVELOPED WHEREBY SULFHYDRL GROUPS WILL BE TRANSFERRED FROM AN ...

    SBIR Phase I 1986 Department of Health and Human Services
  3. ASBESTOS TOXICITY AND CARCINOGENICITY

    Amount: $50,000.00

    THE LONG RANGE OBJECTIVE OF THIS RESEARCH IS TO REDUCE THE TOXICITY AND CARCINOGENICITY OF ASBESTOS BY DESFERROXAMINE TREATMENT, WHICH NEUTRALIZES THE CATALYTIC ACTIVITY OF THE ASBESTOS-CONTAINED IRON ...

    SBIR Phase I 1988 Department of Health and Human Services
  4. SUPERACTIVE B-GALACTOSIDASE FOR ENZYME IMMUNOASSAY

    Amount: $50,000.00

    IN DIAGNOSTIC ENZYME IMMUNOASSAYS (EIA'S), ENZYMES ARE CONJUGATED WITH EITHER ANTIGEN OR ANTIBODY TO AMPLIFY THE PRESENCE OF ANTIGEN-ANTIBODY COMPLEXES. CURRENTLY, BETA-GALACTOSIDASE, HORSERADISH PERO ...

    SBIR Phase I 1989 Department of Health and Human Services
  5. N/A

    Amount: $0.00

    N/A

    SBIR Phase I 2000 Department of Health and Human Services
  6. N/A

    Amount: $378,083.00

    N/A

    SBIR Phase II 2000 Department of Health and Human Services
  7. EPITOPE-SPECIFIC ANTIBODIES FOR ALZHEIMER'S DISEASE

    Amount: $100,000.00

    DESCRIPTION (provided by applicant): Recent attempts at treating Alzheimer's patients with a beta-amyloid vaccine have resulted in an adverse brain inflammation response for a significant number in th ...

    SBIR Phase I 2003 Department of Health and Human Services
  8. EPITOPE-SPECIFIC ANTIBODIES FOR ALZHEIMER'S DISEASE

    Amount: $749,874.00

    DESCRIPTION (provided by applicant): Recent attempts at treating Alzheimer's patients with a beta-amyloid vaccine have resulted in an adverse brain inflammation response for a significant number in th ...

    SBIR Phase II 2004 Department of Health and Human Services
  9. HTS for Protein Splicing Inhibitors as TB Drugs

    Amount: $297,643.00

    DESCRIPTION (provided by applicant): One-third of the world' s population (2 billion people) are infected with Mycobacterium tuberculosis and 5-10% of these suffer active tuberculosis, leading to nea ...

    SBIR Phase I 2003 Department of Health and Human Services
  10. GHRELIN VACCINES FOR CONTROLLING OBESITY

    Amount: $74,098.00

    DESCRIPTION (provided by applicant): Obesity has reached epidemic proportions in the United States and adversely affects the health of both adults and children. While dieting and exercise have had lit ...

    SBIR Phase I 2005 Department of Health and Human Services

Agency Micro-sites


SBA logo

Department of Agriculture logo

Department of Commerce logo

Department of Defense logo

Department of Education logo

Department of Energy logo

Department of Health and Human Services logo

Department of Homeland Security logo

Department of Transportation logo

Enviromental Protection Agency logo

National Aeronautics and Space Administration logo

National Science Foundation logo
US Flag An Official Website of the United States Government